Monika Rüegsegger

Title: Monika Rüegsegger: Innovator in Antibody Research

Introduction

Monika Rüegsegger is a prominent inventor based in Thun, Switzerland. She has made significant contributions to the field of antibody research, particularly in the area of sialylation. Her innovative work has implications for medical applications, including the treatment of various diseases.

Latest Patents

Monika Rüegsegger holds a patent for an "Antibody composition with altered Fab sialylation." This invention relates to a population of antibodies that are enriched from an antibody preparation. The enriched antibodies exhibit an altered amount of sialylation in the Fab region compared to the original preparation. The patent also describes a method for enriching these antibodies and highlights their potential use in medicine, particularly for the prevention and treatment of atherosclerosis, cancer, and infections caused by bacteria, viruses, or fungi. She has 1 patent to her name.

Career Highlights

Throughout her career, Monika has worked with notable organizations, including CSL Behring AG and the University of Washington. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Monika has collaborated with several professionals in her field, including Fabian Käsermann and Sylvia Miescher. These collaborations have enriched her research and expanded the impact of her work.

Conclusion

Monika Rüegsegger is a trailblazer in antibody research, with a focus on enhancing the therapeutic potential of antibodies through innovative sialylation techniques. Her contributions are paving the way for advancements in medical treatments.